PD-L1 in the palm of your hand: palmitoylation as a target for immuno-oncology

被引：9
|
作者：
von Knethen, Andreas [1 ]
Bruene, Bernhard [1 ]
机构：
[1] Goethe Univ Frankfurt, Fac Med, Inst Biochem Pathobiochem 1, Theodor Stern Kai 7, D-60590 Frankfurt, Germany
来源：
SIGNAL TRANSDUCTION AND TARGETED THERAPY | 2019年 / 4卷 / 1期
关键词：
D O I：
10.1038/s41392-019-0053-x
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
引用
收藏
页数：2
相关论文
共 50 条
  • [1] PD-L1 in the palm of your hand: palmitoylation as a target for immuno-oncology
    Andreas von Knethen
    Bernhard Brüne
    Signal Transduction and Targeted Therapy, 4
  • [2] PD-L1 testing by immunohistochemistry in immuno-oncology
    Vranic, Semir
    Gatalica, Zoran
    BIOMOLECULES AND BIOMEDICINE, 2023, 23 (01): : 15 - 25
  • [3] PD-L1 and beyond: Immuno-oncology in cytopathology
    Iaccarino, Antonino
    Salatiello, Maria
    Migliatico, Ilaria
    De Luca, Caterina
    Gragnano, Gianluca
    Russo, Maria
    Bellevicine, Claudio
    Malapelle, Umberto
    Troncone, Giancarlo
    Vigliar, Elena
    CYTOPATHOLOGY, 2021, 32 (05) : 596 - 603
  • [4] The PD-1/PD-L1 Pathway: A Perspective on Comparative Immuno-Oncology
    Schoeniger, Sandra
    Jasani, Bharat
    ANIMALS, 2022, 12 (19):
  • [5] PD-1/PD-L1 Inhibitors for Immuno-oncology: From Antibodies to Small Molecules
    Geng, Qiaohong
    Jiao, Peifu
    Jin, Peng
    Su, Gaoxing
    Dong, Jinlong
    Yan, Bing
    CURRENT PHARMACEUTICAL DESIGN, 2017, 23 (39) : 6033 - 6041
  • [6] PD-L1, inflammation, non-coding RNAs, and neuroblastoma: Immuno-oncology perspective
    Nallasamy, Palanisamy
    Chava, Srinivas
    Verma, Sumit S.
    Mishra, Shruti
    Gorantla, Santhi
    Coulter, Don W.
    Byrareddy, Siddappa N.
    Batra, Surinder K.
    Gupta, Subash C.
    Challagundla, Kishore B.
    SEMINARS IN CANCER BIOLOGY, 2018, 52 : 53 - 65
  • [7] Immuno-oncology in GI tumours: Clinical evidence and emerging trials of PD-1/PD-L1 antagonists
    Stein, Alexander
    Moehler, Markus
    Trojan, Joerg
    Goekkurt, Eray
    Vogel, Arndt
    CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2018, 130 : 13 - 26
  • [8] Molecular Interactions of Antibody Drugs Targeting PD-1, PD-L1, and CTLA-4 in Immuno-Oncology
    Lee, Hyun Tae
    Lee, Sang Hyung
    Heo, Yong-Seok
    MOLECULES, 2019, 24 (06)
  • [9] Immuno-Oncology Biomarkers for Gastric and Gastroesophageal Junction Adenocarcinoma: Why PD-L1 Testing May Not Be Enough
    Weinberg, Benjamin A.
    Xiu, Joanne
    Hwang, Jimmy J.
    Shields, Anthony F.
    Salem, Mohamed E.
    Marshall, John L.
    ONCOLOGIST, 2018, 23 (10): : 1171 - 1177
  • [10] Immuno-oncology moves beyond PD-1
    Cormac Sheridan
    Nature Biotechnology, 2015, 33 : 673 - 675
12345